The convergence of traditional and digital biomarkers through AI-assisted biosensing: A new era in translational diagnostics?
Biosensors and Bioelectronics · 2023-09 · 235 · 115387
DOI: 10.1016/j.bios.2023.115387 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biosensors and Bioelectronics, 2023-09. Verfasst von Sagar S Arya und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Engineering, Khalifa University of Science and Technology, P.O. Box 127788, Abu Dhabi, United Arab Emirates. Hauptthemen laut MEDLINE: Biosensing Techniques, Wearable Electronic Devices. Die Arbeit wurde bisher 160-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Advances in consumer electronics, alongside the fields of microfluidics and nanotechnology have brought to the fore low-cost wearable/portable smart devices. Although numerous smart devices that track digital biomarkers have been successfully translated from bench-to-bedside, only a few follow the same fate when it comes to track traditional biomarkers. Current practices still involve laboratory-based tests, followed by blood collection, conducted in a clinical setting as they require trained personnel and specialized equipment. In fact, real-time, passive/active and robust sensing of physiological and behavioural data from patients that can feed artificial intelligence (AI)-based models can significantly improve decision-making, diagnosis and treatment at the point-of-procedure, by circumventing conventional methods of sampling, and in person investigation by expert pathologists, who are scarce in developing countries. This review brings together conventional and digital biomarker sensing through portable and autonomous miniaturized devices. We first summarise the technological advances in each field vs the current clinical practices and we conclude by merging the two worlds of traditional and digital biomarkers through AI/ML technologies to improve patient diagnosis and treatment. The fundamental role, limitations and prospects of AI in realizing this potential and enhancing the existing technologies to facilitate the development and clinical translation of "point-of-care" (POC) diagnostics is finally showcased.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Engineering, Khalifa University of Science and Technology, P.O. Box 127788, Abu Dhabi, United Arab Emirates.
- Department of Biomedical Engineering, Khalifa University of Science and Technology, P.O. Box 127788, Abu Dhabi, United Arab Emirates; Interdisciplinary Center for Human Performance, Faculdade de Motricidade Humana, Univ…
- Department of Biomedical Engineering, Khalifa University of Science and Technology, P.O. Box 127788, Abu Dhabi, United Arab Emirates; Healthcare Engineering Innovation Center (HEIC), Khalifa University of Science and Te…
Zitieren
APA
Arya, S. S., Dias, S. B., Jelinek, H. F., Hadjileontiadis, L. J., & Pappa, A. M. (2023). The convergence of traditional and digital biomarkers through AI-assisted biosensing: A new era in translational diagnostics?. Biosensors and Bioelectronics, 235, 115387. https://doi.org/10.1016/j.bios.2023.115387
Vancouver
Arya SS, Dias SB, Jelinek HF, Hadjileontiadis LJ, Pappa AM. The convergence of traditional and digital biomarkers through AI-assisted biosensing: A new era in translational diagnostics?. Biosensors and Bioelectronics. 2023;235:115387. doi:10.1016/j.bios.2023.115387
BibTeX
@article{Arya2023,
author = {Arya, Sagar S and Dias, Sofia B and Jelinek, Herbert F and Hadjileontiadis, Leontios J and Pappa, Anna-Maria},
title = {The convergence of traditional and digital biomarkers through AI-assisted biosensing: A new era in translational diagnostics?},
journal = {Biosensors and Bioelectronics},
year = {2023},
volume = {235},
pages = {115387},
doi = {10.1016/j.bios.2023.115387}
}
EUVIMED